American Banking and Market News logo

The Latest Headlines at American Banking and Market News

Image about Vicor (NASDAQ:VICR) PT Lowered to $35.00

Vicor (NASDAQ:VICR) PT Lowered to $35.00

Vicor (NASDAQ:VICR – Get Free Report) had its target price decreased by investment analysts at Craig Hallum from $40.00 to $35.00 in a research report issued to clients and investors on Wednesday, Benzinga reports. The brokerage... More of this article »
Image about Stephens Reiterates Equal Weight Rating for Veritex (NASDAQ:VBTX)

Stephens Reiterates Equal Weight Rating for Veritex (NASDAQ:VBTX)

Veritex (NASDAQ:VBTX – Get Free Report)‘s stock had its “equal weight” rating reissued by equities researchers at Stephens in a research note issued to investors on Wednesday, Benzinga reports. They presently... More of this article »
Image about Wells Fargo & Company Lowers Ulta Beauty (NASDAQ:ULTA) Price Target to $350.00

Wells Fargo & Company Lowers Ulta Beauty (NASDAQ:ULTA) Price Target to $350.00

Ulta Beauty (NASDAQ:ULTA – Get Free Report) had its price objective cut by analysts at Wells Fargo & Company from $450.00 to $350.00 in a report released on Wednesday, Benzinga reports. The brokerage presently has an “underweight”... More of this article »
Image about Vicor (NASDAQ:VICR) Rating Reiterated by Needham & Company LLC

Vicor (NASDAQ:VICR) Rating Reiterated by Needham & Company LLC

Vicor (NASDAQ:VICR – Get Free Report)‘s stock had its “hold” rating restated by Needham & Company LLC in a report released on Wednesday, Benzinga reports. Other research analysts have also recently issued... More of this article »
Image about FY2028 EPS Estimates for Travere Therapeutics, Inc. (NASDAQ:TVTX) Cut by Analyst

FY2028 EPS Estimates for Travere Therapeutics, Inc. (NASDAQ:TVTX) Cut by Analyst

Travere Therapeutics, Inc. (NASDAQ:TVTX – Free Report) – Stock analysts at HC Wainwright decreased their FY2028 earnings per share estimates for Travere Therapeutics in a report released on Wednesday, April 24th. HC... More of this article »
Image about Analysts Set Expectations for Neurocrine Biosciences, Inc.’s Q1 2025 Earnings (NASDAQ:NBIX)

Analysts Set Expectations for Neurocrine Biosciences, Inc.’s Q1 2025 Earnings (NASDAQ:NBIX)

Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Free Report) – Equities research analysts at William Blair issued their Q1 2025 earnings per share estimates for shares of Neurocrine Biosciences in a research note issued... More of this article »
Image about Equities Analysts Set Expectations for Lexeo Therapeutics, Inc.’s FY2027 Earnings (NASDAQ:LXEO)

Equities Analysts Set Expectations for Lexeo Therapeutics, Inc.’s FY2027 Earnings (NASDAQ:LXEO)

Lexeo Therapeutics, Inc. (NASDAQ:LXEO – Free Report) – Research analysts at Leerink Partnrs issued their FY2027 earnings estimates for shares of Lexeo Therapeutics in a note issued to investors on Tuesday, April 23rd.... More of this article »
Image about Sify Technologies Limited (NASDAQ:SIFY) to Post Q4 2026 Earnings of $0.01 Per Share, Sidoti Csr Forecasts

Sify Technologies Limited (NASDAQ:SIFY) to Post Q4 2026 Earnings of $0.01 Per Share, Sidoti Csr Forecasts

Sify Technologies Limited (NASDAQ:SIFY – Free Report) – Equities research analysts at Sidoti Csr lowered their Q4 2026 earnings per share (EPS) estimates for shares of Sify Technologies in a research note issued to investors... More of this article »
Image about Squarespace, Inc. (NYSE:SQSP) Expected to Post FY2027 Earnings of $1.58 Per Share

Squarespace, Inc. (NYSE:SQSP) Expected to Post FY2027 Earnings of $1.58 Per Share

Squarespace, Inc. (NYSE:SQSP – Free Report) – Equities research analysts at B. Riley lifted their FY2027 earnings per share (EPS) estimates for shares of Squarespace in a report issued on Tuesday, April 23rd. B. Riley... More of this article »
Image about Workday, Inc. (NASDAQ:WDAY) to Post FY2027 Earnings of $2.79 Per Share, Zacks Research Forecasts

Workday, Inc. (NASDAQ:WDAY) to Post FY2027 Earnings of $2.79 Per Share, Zacks Research Forecasts

Workday, Inc. (NASDAQ:WDAY – Free Report) – Analysts at Zacks Research upped their FY2027 earnings estimates for shares of Workday in a research note issued on Wednesday, April 24th. Zacks Research analyst R. Department... More of this article »
Image about Barrington Research Equities Analysts Boost Earnings Estimates for National CineMedia, Inc. (NASDAQ:NCMI)

Barrington Research Equities Analysts Boost Earnings Estimates for National CineMedia, Inc. (NASDAQ:NCMI)

National CineMedia, Inc. (NASDAQ:NCMI – Free Report) – Equities researchers at Barrington Research lifted their Q1 2025 EPS estimates for National CineMedia in a research report issued on Monday, April 22nd. Barrington... More of this article »
Image about Seaport Res Ptn Weighs in on The Sherwin-Williams Company’s Q1 2025 Earnings (NYSE:SHW)

Seaport Res Ptn Weighs in on The Sherwin-Williams Company’s Q1 2025 Earnings (NYSE:SHW)

The Sherwin-Williams Company (NYSE:SHW – Free Report) – Seaport Res Ptn issued their Q1 2025 earnings per share estimates for shares of Sherwin-Williams in a research note issued to investors on Tuesday, April 23rd.... More of this article »
Image about Q1 2025 EPS Estimates for Matador Resources Raised by Roth Capital (NYSE:MTDR)

Q1 2025 EPS Estimates for Matador Resources Raised by Roth Capital (NYSE:MTDR)

Matador Resources (NYSE:MTDR – Free Report) – Stock analysts at Roth Capital raised their Q1 2025 earnings per share estimates for Matador Resources in a research note issued on Wednesday, April 24th. Roth Capital analyst... More of this article »
Image about Popular (NASDAQ:BPOP) PT Raised to $115.00

Popular (NASDAQ:BPOP) PT Raised to $115.00

Popular (NASDAQ:BPOP – Get Free Report) had its price target lifted by Wells Fargo & Company from $105.00 to $115.00 in a research note issued on Wednesday, Benzinga reports. The brokerage currently has an “overweight”... More of this article »
Image about Popular (NASDAQ:BPOP) Rating Reiterated by Keefe, Bruyette & Woods

Popular (NASDAQ:BPOP) Rating Reiterated by Keefe, Bruyette & Woods

Popular (NASDAQ:BPOP – Get Free Report)‘s stock had its “outperform” rating reiterated by analysts at Keefe, Bruyette & Woods in a report issued on Wednesday, Benzinga reports. They currently have a $110.00... More of this article »